Approximately two-thirds of pediatric AML is cytogenetically abnormal, indicating the presence of visually identifiable, and often recurrent, chromosomal rearrangements, such as KMT2A (11q23) rearrangements. This evidence concerns the gene KMT2A and acute myeloid leukemia.